Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment side-effects news

Show

From To
Ordeal of hepatitis C treatment worth it

Daniel Berrner was diagnosed with HIV and hepatitis C in 2005, but it took four years to get the HIV infection under control enough to tackle the hepatitis C. This is his personal story of hepatitis C treatment.

Published
12 September 2012
From
San Francisco Chronicle
Hepatitis C drug alisporivir is effective, but pancreatitis a concern

Alisporivir (formerly Debio 025) in interferon-free combinations cured more than 80% of patients with hepatitis C virus (HCV) genotype 2 or 3, researchers reported at the 47th

Published
23 April 2012
By
Liz Highleyman
Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

A real-world study of new hepatitis C protease inhibitors in the group of patients who have been told they should not wait for newer, experimental antivirals has

Published
20 April 2012
By
Keith Alcorn
Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C

A new form of pegylated interferon is associated with significantly fewer side-effects than the standard form of the drug, a study conducted in patients with the easier-to-treat

Published
20 April 2012
By
Michael Carter
Common side-effects of hepatitis C protease inhibitors: clinical management advice published

The addition of the protease inhibitors telaprevir or boceprevir to hepatitis C treatment regimens increases the risk of anaemia, according to a review article published in Liver International.

Published
20 January 2012
By
Michael Carter
Coffee consumption reduces side-effects in people on hepatitis C treatment

Drinking three or more cups of coffee a day reduced the incidence of self-reported side-effects by more than 80% compared to non-coffee drinkers in people co-infected with hepatitis

Published
14 September 2011
By
Gus Cairns
HIV/HCV co-infected women more likely to stop HCV therapy

HIV/hepatitis C-co-infected women were more likely to experience side-effects that lead to the discontinuation or modification of hepatitis C therapy, US investigators report in the online edition of

Published
14 September 2010
By
Michael Carter
Combinations and conundrums: the challenges of hepatitis C treatment

A multiplicity of new drugs for hepatitis C are being researched. As Gus Cairns discovers, though, they face an elusive enemy, a shape-shifter of a virus that won’t

Published
01 July 2009
From
HIV treatment update
← Prev12345Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.